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Abstract We describe a case of successful treatment to
nonunion after multiple arthrodesis operations for Charcot
arthropathy with teriparatide. We describe the case of a 25-
year-old woman with severe Type I diabetes mellitus that
resulted in nonunion after multiple arthrodesis operations
for Charcot arthropathy. The woman sustained a femoral
shaft fracture for which she underwent surgery with
intramedullary nail fixation. Immediately after surgery, an
empiric course of teriparatide was initiated. Femoral shaft
fracture healing was observed after 2 weeks, and the woman
was able to walk 12 weeks after the surgery, at which point
plain film and computed tomography images revealed com-
plete union of the ankle.
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Introduction
Arthrodesis is required for treating severe osteoarthritis ac-
companied by rheumatism, diabetes mellitus, chronic renal
failure, and similar systemic diseases [1]. Nonunion of ar-
throdesis represents the most dramatic example of poor
healing where the normal biologic healing process is insuf-
ficient for achieving complete union, and so surgical treat-
ment of nonunion after arthrodesis is extremely challenging.
Finding another way to treat nonunion after arthrodesis is
therefore imperative. In terms of fracture healing, an accel-
erated effect of teriparatide has been reported in animal
models as well as in several clinical studies [2–4]. Herein,
we report the case of a patient with ankle nonunion who
underwent multiple unsuccessful arthrodesis operations, but
achieved ankle union within 12 weeks with daily
teriparatide administration.
Case report
A 25-year-old Japanese woman sustained a right femoral
shaft fracture while climbing the stairs in May 2012
(Fig. 1a). She denied any abuse or accident such as falling
down the stairs. She had a history of Type 1 diabetes
mellitus, which was poorly controlled with insulin therapy
(HbA1c, 16.7 %), and Charcot arthropathy of the ankle due
to peripheral nerve disorder. An ankle arthrodesis had been
performed at another clinic 15 months ago, but union was
not achieved, and therefore, she underwent further surgery
12 months ago to fix her ankle. This treatment also failed
resulting in nonunion, and so the woman was instructed to
wear a patellar tendon-bearing brace for her ankle instability
and pain (Fig. 2a, b). Her laboratory data, including serum
levels of alkaline phosphate, parathyroid hormone, calcium,
and phosphorus, were normal, but her level of 1.25 vitamin
D3 was low, and her left femoral bone density was extreme-
ly low (0.54 mg/cm2) and 2.0 standard deviations below the
normal value for her age (Table 1).
We treated the femoral shaft fracture with intramedullary
nail fixation 29 days after the fracture occurred, because her
chronic heart failure was too poor to allow for immediate
surgery. We initiated teriparatide (20-μg subcutaneous in-
jection daily) and alfacalcidol (1-μg oral administration
daily) immediately after surgery because of severe osteopo-
rosis and in an attempt to accelerate healing of the femoral
fracture. There was no immobilization of the femur, but a
non-weight-bearing period of 4 weeks was implemented
postoperatively. From 2 weeks after the initiation of
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teriparatide therapy, plain radiography began showing callus
formation on the femoral shaft fracture, and after 12 weeks,
almost complete healing of the fractured bone was observed
(Fig. 1b, c). We therefore allowed the woman to walk with
full weight bearing. We noticed that her ankle pain
disappeared once she had resumed walking. Radiography
and computed tomography images revealed that union of the
ankle had been achieved (Fig. 2c, d). No side effects attrib-
utable to the drug were observed during treatment, and her
subsequent laboratory findings continued to be normal. At
6 months, the patient could walk without a brace and with-
out any pain. Plain images taken at this time revealed
complete healing of the fractured and nonunion sites.
b ca
Fig. 1 Radiographs of the
femur. a 3D computed
tomography images revealed an
oblique fracture of the proximal
shaft of the femur. b Plain film
taken 2 weeks after surgery.
Callus formation is visible
around the fracture site. c Plain
film taken 12 weeks after





Fig. 2 Radiographs of the femur. a Plain film of the ankle with
Charcot arthropathy before arthrodesis. b Plain film taken before
teriparatide therapy was initiated showing atrophic nonunion of the
ankle. c Plain film and sagittal CT images showing atrophic nonunion
of the ankle after multiple arthrodesis operations. d Plain film and
sagittal CT image taken after 12 weeks of teriparatide therapy showing
complete healing of nonunion







Total 6.7–8.3 7.5 7.2
Albumin 3.9–4.9 3.1 3.5
ALP (IU/l) 104–338 281 1033
BUN (mg/dl) 8.0–20.0 21.7 19.1
Cre (mg/dl) 0.36–1.06 0.67 0.61
Na (mEq/l) 136–147 136 134
K (mEq/l) 3.6–5.0 4.6 4.9
Cl (mEq/l) 98–109 94 99
Ca (mEq/l) 8.8–10.2 9.8 9.1
IP (mEq/l) 2.5–4.5 4.1 3.6
Mg (mEq/l) 1.8–2.4 2 1.9
HbA1c (%) 4.6–6.2 13.5 13.2
ACTH (pg/ml) 7.2–63.3 22.4
Intact-PTH (pg/ml) 10–65 31
Calcitonin (pg/ml) 15–86 35




D-Pyr (nM/mM· Cr) 2.8–7.6 31.8 21.6
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Discussion
Amajor problem for patients with chronic diabetes mellitus is
the development of peripheral neuropathy. Sensory loss leads
to neuropathic ulceration, which is aggravated in the presence
of foot and ankle deformities and causes excessive pressure on
deformed areas, a condition that is known as Charcot arthrop-
athy or diabetic ankle [5, 6]. The main aims when treating
Charcot arthropathy of the foot and ankle are to correct the
deformity so that there is an appropriate distribution of pres-
sure for healing and to prevent skin ulceration [7]. Surgical
correction with internal fixation for Charcot arthropathy is
associated with a high rate of complications and failure be-
cause of infection, bone softening, resorption, fragmentation,
and breakage of the implant [8]. Our patient with severe Type I
diabetes mellitus and Charcot arthropathy had undergone two
failed operations. Ankle union was not achieved even after the
second operation, and the patient sustained a femoral shaft
fracture. Nonunion is a severe complication and has a negative
impact on the quality of life; undoubtedly, a second interven-
tion is therefore necessary, but it is not exempt from further
risks and potential complications [9]. It is therefore important
that some treatment that can resolve this problem should be
undertaken, but a third surgery to fix nonunion is extremely
difficult as the ankle needs to be stabilized and the bone needs
to be strengthened.
Teriparatide (rhPTH 1–34) is an anabolic agent that is
administered subcutaneously. Its anabolic effect is attributable
to the stimulation of osteoblasts, which causes a net increase
in both cancellous and cortical bone, thus improving the bone
architecture [10, 11]. Teriparatide has different effects on
trabecular and cortical bone. Because of the high degree of
remodeling and apoptosis of trabecular bone osteoblasts,
teriparatide has a more profound effect on trabecular than on
cortical bone, which has a lower degree of osteoblastic apo-
ptosis [2]. Teriparatide also accelerates fracture healing by
improving the biomechanical properties of the fracture callus
and by increasing endochondral ossification and bone remod-
eling in animal models [3]. This effect has also been observed
in several other clinical case reports [12–14]. In a more de-
tailed prospective, randomized, double-blinded study in 102
postmenopausal women who underwent conservative treat-
ment for distal radial fractures, Aspenberg [4] showed that the
time to healing was shorter in the 20-mg teriparatide group
than in the placebo group. These reports indicate that
teriparatide accelerates healing of bone fractures.
Chintamaneni [1] described a case of nonunion in the body
of the sternum of a 67-year-old man, and Rubery and Bukata
[15] described a series of three cases of nonunion in type III
odontoid fractures treated conservatively with external immo-
bilization. These patients were all successfully treated with
teriparatide after conservative therapy for nonunion. Alvaro
[16] described a case of atrophic humeral shaft nonunion after
intramedullary osteosynthesis with elastic nails, and Lee
[17] described three cases of femoral nonunion after
surgical fixation. Our patient was administered with
teriparatide for 12 months after the diagnosis of non-
union. Union was obtained within 3 months at both the
fracture and nonunion sites, and no adverse events oc-
curred during or after treatment. To our knowledge, this
is the first study to report successful treatment of nonunion
after arthrodesis for Charcot arthropathy and accelerated frac-
ture healing after teriparatide administration.
We report that teriparatide is a possible alternative to
surgical intervention in difficult cases of nonunion. Well-
designed studies are warranted to verify the efficacy of this
approach.
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